NIDA Center
navigation
   

Molecular Basis of Drug Addiction
Pharmacology 534 - Autumn 2012

C Chavkin, N Stella, J Neumaier, P Phillips, L Zweifel, S Ferguson - Instructors

The class format starts with an introduction by the instructor followed by a discussion of the papers listed. Students are expected to have read the papers beforehand, and come to class prepared to discuss the methods, experimental design, and principal conclusion of the assigned papers. The course is designed to enhance the critical reading skills of the students and to familiarize the students with the strengths and limits of the key techniques in this research area.

9/27/12
3:30-5:30 PM
Cannabinoids and addictive drugs: neuronal populations (Stella) Katona I, Freund TF. (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med. 14(9):923-30.
 
Häring M, Kaiser N, Monory K, Lutz B. (2011) Circuit specific functions of cannabinoid CB1 receptor in the balance of investigatory drive and exploration. PLoS One. 6(11):e26617.
 
Corbillé AG, Valjent E, Marsicano G, Ledent C, Lutz B, Hervé D, Girault JA. (2007) Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. J Neurosci. 27(26):6937-47.
 
Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, Yang HJ, Bi GH, Li J, Gardner EL. (2011) Brain cannabinoid CB? receptors modulate cocaine's actions in mice. Nat Neurosci. 14(9):1160-6.
10/4/12
3:30-5:30 PM
Striatal dopamine D2 receptors and addiction (Phillips) Volkow ND et al (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56:3-8 [review].
 
Morgan D et al (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169-74.
 
Volkow ND et al (2006) High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. ArchGen Psychiatry 63:999-1008.
10/11/12
3:30-5:30 PM
Endocannabinoid synthesis, signal transduction (Stella) Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 95(16):9608-13.
 
Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA. (2009) Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc Natl Acad Sci U S A. 106(26):10847-52.
 
Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O'Brien CP. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology. 28(8):1546-52.
10/18/12
3:30-5:30 PM
Plasticity associated with withdrawal and craving (Neumaier) Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, Shaham Y. (2011) Neurobiology of the incubation of drug craving. Trends Neurosci. 34(8):411-20.
 
Dobi A, Seabold GK, Christensen CH, Bock R, Alvarez VA. (2011) Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal. J Neurosci. 2011 Feb 2;31(5):1895-904.
 
McCutcheon JE, Loweth JA, Ford KA, Marinelli M, Wolf ME, Tseng KY. (2011) Group I mGluR activation reverses cocaine-induced accumulation of calcium-permeable AMPA receptors in nucleus accumbens synapses via a protein kinase C-dependent mechanism. J Neurosci. 31(41):14536-41.
 
Pascoli V, Turiault M, Lüscher C. (2011) Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature. 481(7379):71-5.
10/25/12
3:30-5:30 PM
Drug-induced plasticity in dopamine neurons (Zweifel) Mameli M, Bellone C, Brown MT, Lüscher C. (2011) Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area. Nat Neurosci. 14(4):414-6.
 
Bellone C, Lüscher C. (2006) Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci. 9(5):636-41.
 
Lüscher C, Malenka RC. (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron. 69(4):650-63
 
Ungless MA, Whistler JL, Malenka RC, Bonci A. (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature. 411(6837):583-7.
11/1/12
3:30-5:30 PM
Striatal circuitry and drug-seeking (Ferguson) Corbit LH, Nie H and Janak PH (2012) Habitual alcohol seeking: time course and the contribution of subregions of the dorsal striatum. Biological Psychiatry 72:389-395.
 
Zapata A, Minney VL, Shippenberg TS (2010) Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. J Neurosci 30:15457-63.
 
Belin-Rauscent A, Everitt BJ and Belin D (2012) Intrastriatal shifts mediate the transition from drug-seeking actions to habits. Biological Psychiatry 72:343-345.
 
Haber SN (2011) Neuroanatomy of reward: A view from the ventral striatum. In Neurobiology of sensation and reward. Gottfried JA, editor. Boca Raton (FL): CRC Press.
11/8/12
3:30-5:30 PM
Neurochemical changes associated with escalated and compulsive drug use(Phillips) Jonkman S, Pelloux Y, Everitt BJ (2012a) Drug intake is sufficient, but conditioning is not necessary for the emergence of compulsive cocaine seeking after extended self-administration. Neuropsychopharmacology. 37(7):1612-9.  
 
Jonkman S, Pelloux Y, Everitt BJ (2012b) Differential roles of the dorsolateral and midlateral striatum in punished cocaine seeking. J Neurosci. 32(13):4645-50. PubMed PMID: 22457510.  
 
Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ (2012) Reduced Forebrain Serotonin Transmission is Causally Involved in the Development of Compulsive Cocaine Seeking in Rats. Neuropsychopharmacology. 37(11):2505-14.
11/15/12
3:30-5:30 PM
Serotonin receptors & Hallucinogens (Neumaier) McGregor IS, Bowen MT. (2012) Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm Behav. 61(3):331-9.
 
González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 53(3):439-52.
 
Fribourg M, Moreno JL, Holloway T, Provasi D, Baki L, Mahajan R, Park G, Adney SK, Hatcher C, Eltit JM, Ruta JD, Albizu L, Li Z, Umali A, Shim J, Fabiato A, MacKerell AD Jr, Brezina V, Sealfon SC, Filizola M, González-Maeso J, Logothetis DE. (2011) Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell. 147(5):1011-23.
11/29/12 Stress potentiation of addiction risk (Chavkin) Sinha R. (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 1141:105-30. Review.
 
Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, Lemos JC, Hagan CE, Neumaier JF, Quintana A, Palmiter RD, Chavkin C. (2011) Selective p38? MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron. 71(3):498-511.
 
Vendruscolo LF, Barbier E, Schlosburg JE, Misra KK, Whitfield TW Jr, Logrip ML, Rivier C, Repunte-Canonigo V, Zorrilla EP, Sanna PP, Heilig M, Koob GF. (2012) Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J Neurosci. 32(22):7563-71.
 
Walker BM, Koob GF. (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology. 33(3):643-52.
12/6/12
3:30-5:30 PM
Cannabinoids and drug addiction: molecular details(Stella) Marrs W, Stella N. (2009) Measuring endocannabinoid hydrolysis: refining our tools and understanding. AAPS J. 11(2):307-11.
 
Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH, Cravatt BF. (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci. 13(9):1113-9
 
Gutierrez T, Crystal JD, Zvonok AM, Makriyannis A, Hohmann AG. (2011) Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain. Pain. 152:1976-87